Subtopic Deep Dive
Economic Impact of Health Litigation
Research Guide
What is Economic Impact of Health Litigation?
Economic Impact of Health Litigation quantifies fiscal costs of judicial demands for health services and medications on Brazil's Sistema Único de Saúde (SUS) budgets using econometric models.
Researchers analyze court-ordered provisions of non-standardized drugs like semaglutida and diabetes treatments, forecasting budget sustainability (Pereira et al., 2024; Rodrigues-Pinto, 2016). Studies document rising judicial cases in regions like Distrito Federal and Juiz de Fora, with no foundational papers pre-2015 available. Seven recent papers, all with 0 citations, employ integrative reviews and acquisition analyses.
Why It Matters
Judicial health demands strain SUS budgets, as seen in semaglutida acquisitions despite non-incorporation (Pereira et al., 2024) and diabetes treatment costs in Minas Gerais (Rodrigues-Pinto, 2016). Fernandes et al. (2025) highlight non-Conitec recommended technologies in Distrito Federal, threatening fiscal viability. Evidence supports policy reforms for judicial guidelines, strengthening industrial health complexes (Vieira et al., 2024).
Key Research Challenges
Quantifying Hidden Fiscal Costs
Estimating total SUS expenditures from unreported judicial orders remains difficult due to fragmented data across states (Rodrigues-Pinto, 2016). Pereira et al. (2024) note challenges in tracking off-protocol drugs like semaglutida. Econometric models require comprehensive judicial and budget datasets.
Forecasting Long-term Budget Strain
Predicting sustainability amid rising litigation lacks longitudinal data (Andrade and Aciole, 2021). Integrative reviews reveal gaps in forecasting methods for non-standard medications (Galvão, 2025). Policy impact assessments are underdeveloped.
Evaluating Policy Reform Effectiveness
Assessing judicial guidelines' impact on litigation rates faces causal inference issues (Fernandes et al., 2025). Vieira et al. (2024) emphasize strengthening CEIS but lack empirical tests. Standardization protocols need econometric validation.
Essential Papers
Contexto da Judicialização no Distrito Federal de Tecnologias em Saúde Não Recomendadas pela Conitec
Viviane Corrêa de Almeida Fernandes, Samara Haddad Simões Machado, Débora Santos Lula Barros · 2025 · Epidemiologia e Serviços de Saúde · 0 citations
Introdução: O Sistema Único de Saúde (SUS) garantiu o acesso integral e universal ao cuidado à saúde. O acesso ao medicamento pelo SUS ainda apresenta percalços. Ademais, o acesso ao medicamento é ...
Análise das aquisições de semaglutida no Sistema Único de Saúde entre 2022 e 2023
Marcelo Tavares Pereira, Gilson Pires Dorneles, Ellen Daiane Biavatti de Oliveira Algeri et al. · 2024 · Jornal de Assistência Farmacêutica e Farmacoeconomia · 0 citations
Introdução Semaglutida tem indicação de uso registrado na Agência Nacional de Vigilância Sanitária (Anvisa) para Diabetes Mellitus 2 (DM2), e mais recentemente para o tratamento de obesidade e sobr...
A IMPORTÂNCIA ESTRATÉGICA DO FORTALECIMENTO DO COMPLEXO ECONÔMICO-INDUSTRIAL DA SAÚDE (CEIS) PARA O AMPLO ACESSO A MEDICAMENTOS NO SISTEMA ÚNICO DE SAÚDE
Camilli Moisinho Vieira, Nylza Maria Tavares Gonçalves, Leonardo Guimarães de Andrade · 2024 · Revista Ibero-Americana de Humanidades, Ciências e Educação · 0 citations
A Constituição Federal de 1988 legitimou a saúde como direito de todos e dever do Estado, estabelecendo o Sistema Único de Saúde (SUS), como um dos maiores sistemas públicos de saúde do mundo, resp...
JUDICIALIZAÇÃO DA SAÚDE E O SISTEMA ÚNICO DE SAÚDE: O QUE DIZEM AS INFORMAÇÕES JUDICIAIS?
Matheus Martins de Andrade, Giovanni Gurgel Aciole · 2021 · Saúde em Redes · 0 citations
INTRODUÇÃO: a judicialização da saúde é um tema em ascensão no Brasil, com aumento no número de casos levados ao poder judiciário e na produção científica relacionada ao assunto. Concomitantemente,...
O Direito ao Medicamento pela Via Judicial: revisão integrativa de literatura
Ecleziast de Paula Galvão · 2025 · Cuadernos de Educación y Desarrollo · 0 citations
O presente artigo tem como objetivo identificar publicações que caracterizam as ações judiciais relacionadas ao fornecimento de medicamentos, a partir da literatura científica disponível. A pesquis...
Revisão integrativa sobre o acesso aos antimicrobianos no tratamento das infecções bacterianas de pele e tecidos moles complicadas na saúde pública
Jaqueline Pilon de Meneses, Samara Jamile Mendes · 2025 · JMPHC | Journal of Management & Primary Health Care | ISSN 2179-6750 · 0 citations
A Organização das Nações Unidas declara que o acesso aos medicamentos deve constituir um direito humano com premissas a ser norteadora em detrimento das expectativas do mercado. A Assistência Farma...
Custos médicos diretos dos tratamentos para diabetes mellitus solicitados por via judicial no município de Juiz de Fora, Minas Gerais
Paula Camila Rodrigues-Pinto · 2016 · Americanae (AECID Library) · 0 citations
O diabetes mellitus é considerado uma epidemia mundial pela Organização Mundial de Saúde. Tanto a prevalência, quanto a incidência dos dois tipos principais (1 e 2) têm aumentado a cada ano. No Bra...
Reading Guide
Foundational Papers
No pre-2015 papers available; start with Rodrigues-Pinto (2016) for baseline diabetes judicial costs in Juiz de Fora.
Recent Advances
Pereira et al. (2024) for semaglutida acquisitions; Fernandes et al. (2025) for Distrito Federal non-Conitec demands.
Core Methods
Integrative literature reviews (Galvão, 2025), acquisition tracking (Pereira et al., 2024), and judicial data analysis (Andrade and Aciole, 2021).
How PapersFlow Helps You Research Economic Impact of Health Litigation
Discover & Search
Research Agent uses searchPapers and exaSearch to find all Brazilian papers on SUS judicial costs, surfacing Pereira et al. (2024) on semaglutida acquisitions. citationGraph reveals connections to Fernandes et al. (2025); findSimilarPapers expands to regional cases like Rodrigues-Pinto (2016).
Analyze & Verify
Analysis Agent applies readPaperContent to extract cost data from Rodrigues-Pinto (2016), then runPythonAnalysis with pandas for econometric verification of diabetes treatment expenses. verifyResponse (CoVe) checks claims against GRADE grading for evidence quality in judicial demand studies; statistical tests confirm budget impact correlations.
Synthesize & Write
Synthesis Agent detects gaps in forecasting models across papers, flagging contradictions in litigation trends (Andrade and Aciole, 2021 vs. Galvão, 2025). Writing Agent uses latexEditText, latexSyncCitations for reform proposals, and latexCompile to generate policy reports with exportMermaid diagrams of cost flows.
Use Cases
"Run econometric regression on judicial diabetes treatment costs from Rodrigues-Pinto 2016."
Analysis Agent → readPaperContent → runPythonAnalysis (pandas/NumPy regression on extracted costs) → matplotlib plot of SUS budget impact.
"Draft LaTeX policy brief on semaglutida judicialization economic effects."
Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Pereira et al. 2024) → latexCompile → PDF with cost projections.
"Find code for modeling health litigation fiscal forecasts in Brazil."
Research Agent → paperExtractUrls (from Vieira et al. 2024) → Code Discovery → paperFindGithubRepo → githubRepoInspect → econometric simulation scripts.
Automated Workflows
Deep Research workflow conducts systematic review of 50+ SUS judicialization papers, chaining searchPapers → citationGraph → structured fiscal cost report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Pereira et al. (2024) acquisition data. Theorizer generates policy reform theories from litigation trends in Fernandes et al. (2025).
Frequently Asked Questions
What defines Economic Impact of Health Litigation?
It quantifies fiscal costs of court-ordered health provisions on SUS budgets via econometric models, as in diabetes cases (Rodrigues-Pinto, 2016).
What methods analyze these impacts?
Integrative reviews and acquisition analyses track non-protocol drugs (Pereira et al., 2024; Galvão, 2025); econometric modeling estimates budget strains.
What are key papers?
Pereira et al. (2024) on semaglutida; Fernandes et al. (2025) on Distrito Federal cases; Rodrigues-Pinto (2016) on diabetes costs; all 0 citations.
What open problems exist?
Longitudinal forecasting of litigation costs and causal policy impact assessments lack data (Andrade and Aciole, 2021; Vieira et al., 2024).
Research Public Health in Brazil with AI
PapersFlow provides specialized AI tools for Social Sciences researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Find Disagreement
Discover conflicting findings and counter-evidence
See how researchers in Social Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Economic Impact of Health Litigation with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Social Sciences researchers
Part of the Public Health in Brazil Research Guide